期刊文献+

对我院2003~2006年急性淋巴细胞白血病患者甲氨蝶呤血药浓度监测结果的统计分析

Statistical analysis of methotrexate serum concentration of patients with acute lymphocytic leukemia in our hospital during 2003~2006
暂未订购
导出
摘要 采用荧光偏振免疫分析法,对2003~2006年我院急性淋巴细胞白血病患者MTX血药浓度进行监测。通过对监测结果的统计分析发现,根据不同时间点的MTX血药浓度指导临床亚叶酸钙“解救”,MTX基本都能降至安全浓度范围内,表明MTX血液浓度监测可以减少其毒副作用的产生,对临床治疗有着重要意义。 The methotrexate (MTX) serum concentration of patients with acute lymphocytic leukemia in our hospital during 2003 - 2006 was monitored by fluorescence polarization immunoassay. According to statistical monitoring results at different time points, most of the MTX serum concentration rescued by calcium folinate could successfully drop to the safe range, and a decrease of toxic reactions was also observed. But we also noticed some problems from this statistics and analysis, and wish to improve and consummate them in the future.
出处 《药学与临床研究》 2007年第6期487-489,共3页 Pharmaceutical and Clinical Research
关键词 血药浓度监测 甲氨蝶呤 急性淋巴细胞白血病 解救 Serum concentration monitoring Methotrexate Acute lymphocytic leukemia(ALL) Rescue
  • 相关文献

参考文献3

二级参考文献44

  • 1刘志刚,吴红艳,张宝琴.大剂量甲氨喋呤治疗儿童白血病临床研究[J].中国现代医学杂志,2005,15(1):73-75. 被引量:10
  • 2杨丽华,卢新天,卢炜,吴克华,华瑛,赵卫红.大剂量甲氨喋呤在急性白血病患儿体内的群体药动学[J].中国药学杂志,2005,40(13):1007-1012. 被引量:25
  • 3彭健,姚敏元.大剂量氨甲喋呤治疗儿童急性淋巴细胞白血病的药代动力学[J].中国药房,1996,7(2):77-77. 被引量:13
  • 4顾龙君 应大明 等.大剂量氨甲蝶呤对急性淋巴细胞白血病庇护所治疗的探讨[J].中华血液学杂志,1986,7(5):277-286.
  • 5Odoul F, Leguellec C,Lamagnere JP,et al. Prediction of methotrexateelimination after high dose infusion in children with acute lymphoblastic leukemia using a population pharmacokinetic approach. Fundam Clin Parmacol, 1999, 13: 595-604.
  • 6Rask C, Albert F, Bentzen SM, et al. Clinical and pharmacokinetic risk factors for high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia--a logistic regression analysis.Acta Oncol,1998, 37: 277-284.
  • 7Galpin AJ,Schuetz JD, Masson E, et al. Differences in folypolyglutamatate synthetase and dihydrofolate reductase expression in human Blineage versus T-lineage lymphoblastic leukemia: mechanisms for lineage difference in methotrexate polyglutamylation and cytotoxicity.Mol Pharmacol, 1997, 52: 155-163.
  • 8Krause AS,Weihrauch MR,Bode U,et al.Carboxypeptidase-G2 rescue in cancer patients with delayed methotrexate elimination after high-dose methotrexate therapy[J].Leuk Lymphoma.2002,43 (11):2139-2143.
  • 9Dagdemir A,Yildirim H,Aliyazicioglu Y,et al.Does vitamin A prevent high-dose-methotrexate-induced D-xylose malabsorption in children with cancer?[J].Support Care Cancer,2004,12(4):263-267.
  • 10Hashimoto H,Kubota M,Shimizu T,et al.Effect of high-dose methotrexate on plasma hypoxanthine and uridine levels in patients with acute leukemia or non-Hodgkin lymphoma in childhood[J].Leukemia.1992,6(11):1199-1202.

共引文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部